| Literature DB >> 34946780 |
Anna Santin1, Monia Teresa Russo1, Maria Immacolata Ferrante1, Sergio Balzano1,2, Ida Orefice1, Angela Sardo1,3.
Abstract
Microalgae have a great potential for the production of healthy food and feed supplements. Their ability to convert carbon into high-value compounds and to be cultured in large scale without interfering with crop cultivation makes these photosynthetic microorganisms promising for the sustainable production of lipids. In particular, microalgae represent an alternative source of polyunsaturated fatty acids (PUFAs), whose consumption is related to various health benefits for humans and animals. In recent years, several strategies to improve PUFAs' production in microalgae have been investigated. Such strategies include selecting the best performing species and strains and the optimization of culturing conditions, with special emphasis on the different cultivation systems and the effect of different abiotic factors on PUFAs' accumulation in microalgae. Moreover, developments and results obtained through the most modern genetic and metabolic engineering techniques are described, focusing on the strategies that lead to an increased lipid production or an altered PUFAs' profile. Additionally, we provide an overview of biotechnological applications of PUFAs derived from microalgae as safe and sustainable organisms, such as aquafeed and food ingredients, and of the main techniques (and their related issues) for PUFAs' extraction and purification from microalgal biomass.Entities:
Keywords: genetic engineering; growth conditions; marketable PUFAs; microalgae; polyunsaturated fatty acids (PUFAs); sustainable processes
Mesh:
Substances:
Year: 2021 PMID: 34946780 PMCID: PMC8707597 DOI: 10.3390/molecules26247697
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Main polyunsaturated fatty acid (PUFA)-producing microorganisms and associated high-value products.
Main polyunsaturated fatty acids (PUFAs): common and IUPAC names, acronyms, and structural formulas.
| Fatty Acid | Acronym | IUPAC Name | Structure |
|---|---|---|---|
| Palmitic acid | PA | Hexadecanoic acid |
|
| Stearic acid | SA | Octadecanoic acid |
|
| Oleic acid | OA | (9Z)-Octadec-9-enoic acid |
|
| Linoleic acid (C18:2ω6) | LA | (9Z,12Z)-Octadeca-9,12-dienoic acid |
|
| α-linolenic acid | ALA | (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid |
|
| γ-linolenic acid | GLA | (6Z,9Z,12Z)-Octadeca-6,9,12-trienoic acid |
|
| Eicosatetraenoic acid | ETA | (8Z,11Z,14Z,17Z)-Icosa-8,11,14,17- tetraenoic acid |
|
| Dihomo-γ-linoleic acid | DHGLA | (8Z,11Z,14Z)-Icosa-8,11,14-trienoic acid |
|
| Arachidonic | AA | (5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid |
|
| Eicosapentaenoic acid | EPA | (5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoic acid |
|
| Docosatetraenoic acid | DTA | (7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-tetraenoic acid |
|
| Docosahexaenoic acid | DHA | (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid |
|
| Docosapentaenoic acid | DPA | (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid |
|
Effect of different genetic modifications for enhancing PUFAs’ accumulation in microalgae. Studies are grouped by genetic modification, such as overexpression, silencing/knock-out, and heterologous expression, and then by the pathway in which the gene of interest is involved. The table represents the results obtained through specific genetic modifications. Genes and pathways are reported in Uniprot (https://www.uniprot.org/uniprot, accessed on 29 November 2021). Differences are shown as percentage increases, indicating the surplus over the wild-type control condition.
|
| |||||
|
|
|
|
|
| |
| AGPAT1 | TAG biosynthesis |
| +50% EPA, +50% DHA content, +80% TAG content | [ | |
| GPAT | TAG biosynthesis |
| +41% PUFA content | [ | |
| DGAT2 | TAG biosynthesis |
| +76% EPA content, +35% neutral lipid content | [ | |
| DGAT2 | TAG biosynthesis |
| +100% total lipid, +80% TAG content, +20% EPA content | [ | |
| DGAT2 | TAG biosynthesis |
| +69% neutral lipid content | [ | |
| DGAT1A | TAG biosynthesis |
| +39% TAG content | [ | |
| DGTT1-3 | TAG biosynthesis |
| no changes in lipid content | [ | |
| DGTT4 | TAG biosynthesis |
| +2800%TAG content | [ | |
| GPAT, DGAT2 | TAG biosynthesis |
| +170% total lipid content | [ | |
| GK | TAG biosynthesis |
| +12% total lipid content | [ | |
| GPDH | TAG biosynthesis |
| +60% TAG content | [ | |
| LPAAT1 | TAG biosynthesis |
| +20% TAG content | [ | |
| thioesterase | FA biosynthesis |
| +72% total lipid, +10% EPA content | [ | |
| TE | FA biosynthesis |
| +16% EPA content | [ | |
| ACP, KAS, FAT | FA biosynthesis |
| +100% EPA, +340%DHA content, +32% total FA content | [ | |
| ME | FA biosynthesis |
| +150% total lipid content, −10% PUFA content | [ | |
| MCAT | FA biosynthesis |
| +31% neutral lipid, +8% EPA content | [ | |
| MCAT | FA biosynthesis | +172.5% EPA, +81.5% DHA, +69.2% DPA content | [ | ||
| FA elongase | FA biosynthesis |
| +40% EPA, +350% DHA content | [ | |
| Δ5 desaturase | FA biosynthesis |
| +65% TAG content, +58% EPA content | [ | |
| Δ12 desaturase | FA biosynthesis |
| +75% AA content | [ | |
| bHLH2 | transcription factor |
| +33% total lipid content | [ | |
| DOF | transcription factor |
| +100% total lipid content | [ | |
| DOF | transcription factor |
| +170% total lipid content | [ | |
| PSR1 | transcription factor |
| no quantified reduction of neutral lipid content | [ | |
| PSR1 | transcription factor |
| +10% TAG content | [ | |
| bZIP | transcription factor |
| +50% total lipid content | [ | |
| PNPLA3 | lipid turnover |
| +70% neutral lipid, +26% PUFA content | [ | |
| LDP1 | lipid droplet metabolism |
| +30% total lipid, +40% neutral lipid content | [ | |
| ACCase | pyruvate metabolism |
| no changes in lipid content | [ | |
| G6PD | carbohydrates metabolism |
| +170% total lipid content | [ | |
| NOA | nitric oxide metabolism |
| +80% neutral lipid, +400% TAG content | [ | |
| Silencing | |||||
|---|---|---|---|---|---|
| Gene | Pathway | Method | Microalgal Species | Results | Reference |
| AGPase | Carbohydrates’ metabolism | random mutagenesis |
| +250% total lipids, +900% TAG content | [ |
| isoamylase | Carbohydrates’ metabolism | random mutagenesis |
| +450% total lipid content | [ |
| UGPase | Carbohydrates’ metabolism | TALEN |
| +4400% TAG content | [ |
| UGPase | Carbohydrates’ metabolism | RNAi |
| +4% total lipid content | [ |
| CS | Carbohydrates’ metabolism | RNAi |
| +200% TAG content | [ |
| SLM1 | Carbohydrates’ metabolism | random mutagenesis |
| +51% TAG content | [ |
| PEPC1 | pyruvate metabolism | CRISPRi |
| +74% total lipid content | [ |
| PEPC1 | pyruvate metabolism | RNAi |
| +20% TAG content | [ |
| PEPC1, PEPC2 | pyruvate metabolism | RNAi |
| +48% FA content | [ |
| PEPCK | pyruvate metabolism | RNAi |
| +40% total lipid content | [ |
| CIS | pyruvate metabolism | RNAi |
| +170% TAG content | [ |
| PDK | pyruvate metabolism | RNAi |
| +82% neutral lipid, no changes in FA content | [ |
| lipase | lipid turnover | RNAi |
| +300% EPA, +220% DHA content | [ |
| omTGL | lipid turnover | RNAi |
| +70% EPA content | [ |
| TGL1 | lipid turnover | RNAi |
| +200% TAG, +10% EPA content | [ |
| LIP1 | lipid turnover | RNAi |
| +150% TAG content | [ |
| ACX2 | Β oxidation | insertional mutagenesis |
| +400% neutral lipid, +70% TAG content | [ |
| MLDP | lipid droplet metabolism | RNAi |
| no changes in TAG content | [ |
| LDP1 | lipid droplet metabolism | RNAi |
| −20% total lipid content | [ |
| PDAT | TAG biosynthesis | RNAi |
| general reduction of all TAG classes content | [ |
| SAD | FA biosynthesis | RNAi |
| +40% stearic acid content | [ |
| ω-3-DES | FA biosynthesis | homologous recombination |
| no changes in PUFA and FA content | [ |
| TES1 | FA biosynthesis | TALEN |
| +70% TAG content | [ |
| PDH | FA biosynthesis | RNAi |
| −50% FA content | [ |
| DGTT | FA biosynthesis | RNAi |
| −35% TAG content | [ |
| NR | N assimilation | TALEN |
| +20% TAG content | [ |
| NR | N assimilation | RNAi |
| +43% total lipid content | [ |
| ZnCys | transcription factor | RNAi |
| +35% total lipid content | [ |
| - | - | random mutagenesis |
| +33% EPA, +33% DHA content | [ |
| - | - | insertional mutagenesis |
| +180% PUFA, +40% EPA content | [ |
|
| |||||
|
|
|
|
|
|
|
|
| |||||
| GPAT | TAG biosynthesis |
|
| +50% FA content | [ |
| ELO5 | FA biosynthesis |
|
| +700% DHA content | [ |
| ELO5, DES6 | FA biosynthesis |
|
| +800% DHA content | [ |
| Δ5DES | FA biosynthesis |
|
| +360% EPA, +1220% AA content | [ |
| ME | FA biosynthesis |
|
| +220% neutral lipid content | [ |
| (Bn)AccD, (Cr)ME | pyruvate metabolism |
|
| +12% total lipid content | [ |
| ACCase | pyruvate metabolism |
|
| no changes in lipid content | [ |
| thioesterase | FA biosynthesis |
|
| +50% FA content | [ |
| DGAT2 | TAG biosynthesis |
|
| +85% total lipid content | [ |
|
| |||||
| DGAT2 | TAG biosynthesis |
| +12% ALA content | [ | |
| DGA1 | TAG biosynthesis |
| +130% TAG content | [ | |
| OLEO3 | TAG biosynthesis |
| +40% TAGcontent | [ | |
| (Sc)DGA1, (At)OLEO3 | TAG biosynthesis |
| +260% TAG content | [ | |
| (Sc)G3PDH-GPAT-LPAAT, (Yl)DGATs | TAG biosynthesis |
| +120% total lipid content | [ | |
| Δ3DES | FA biosynthesis | +3% DHA content | [ | ||
| ACP reductase | FA biosynthesis |
| +133% TAG content | [ | |
| (Cc)C14-TE, (Uc)C12-TE | FA biosynthesis |
| +80% TAG content | [ | |
| (Cc)C14-TE, (Uc)C12-TE, (Ch)KAS | FA biosynthesis |
| +4% FA content | [ | |
| C14-TE, C10-TE, ACP | FA biosynthesis |
| general increase in different FAs classes content | [ | |
| (Bn)AccD, (Cr)ME | pyruvate metabolism |
| +12% total lipid content | [ | |
| ACC1 | pyruvate metabolism |
| +60% FA content | [ | |
| ACC1, GDP1, GUT1 | pyruvate metabolism |
| +50% total lipid content | [ | |
| ACS | pyruvate metabolism | no changes in lipid content | [ | ||
| (An)PhyA, (Ot)Elo5 | phytate metabolism |
| +10% DHA, −25% EPA content | [ | |
| (Ec)AppA, (Ot)Elo5 | phytate metabolism |
| +12% DHA, −18% EPA content | [ | |
| DOF4 | transcription factor |
| +53% total lipid content | [ | |
| WRI1 | transcription factor |
| +64% tota lipid content | [ | |
|
| |||||
| antisense PEPC | pyruvate metabolism | +47% lipid content | [ | ||
| ACCase | pyruvate metabolism |
| +100% neutral lipid content | [ | |
| Δ9-ELO | FA biosynthesis |
| +18% PUFA content | [ | |
| Δ9-ELO (codon optimized) | FA biosynthesis |
| +64% PUFA content | [ | |
| Δ6-DES | FA biosynthesis |
| +26% EPA content | [ | |
| (Ig)Δ9E, (Eg)Δ8D, (Ma)Δ5D | FA biosynthesis |
| +23% PUFA, +3% EPA, +7% AA content | [ | |
| (Pt)Δ5D, (Pt)Δ6D, (Pp)Δ6E | FA biosynthesis |
| +30% PUFA content | [ | |
| (Pt)Δ5D, (Pt)Δ6D, (Pp)Δ6E | FA biosynthesis |
| +30% PUFA content | [ | |
| (Sc)PUFA-synthase, (No)PPTase | FA biosynthesis | +4% DHA, +1% EPA content | [ | ||
| ELO5 | FA biosynthesis |
| no quantified increase in DPA and DTA content | [ | |
| (Pt)ELO5, (Is)DES4 | FA biosynthesis |
| +3% DPA, +2.35% DHA content | [ | |
| DES2 | FA biosynthesis |
| no quantified reduction of LA content | [ | |
| DGTT2 | FA biosynthesis |
| +800% TAG content | [ | |
| (Pt)Δ5D, (Pt)Δ6D, (Pp)Δ6E | FA biosynthesis |
| +0.23% EPA, +0.17% AA content | [ | |
| DES6 | FA biosynthesis |
| +2500% EPA content | [ | |
| Δ6ELO | FA biosynthesis |
| +6% SDA, +3% GLA content | [ | |
| (Iso)Δ6ELO, (Pav)Δ5DES | FA biosynthesis | no quantified increase of AA and EPA content | [ | ||
Figure 2Schematic representation of microalgal lipid pathways. The enzymes are shown in squares with different colors, depending on the genetic manipulation that occurred: red for silencing or knock-out, green for overexpression, and blue for heterologous expression. Cellular organelles involved are plastid, endoplasmic reticulum, peroxisome, mitochondria cytosol, and nucleus. The numbers (from 1 to 6) near the square brackets indicate different figure sections. AA: Arachidonic Acid; ACCase: Acetyl-CoA Carboxylase; ACP: Acyl Carrier Protein; ADP-glucose: Adenosine-Diphosphate Glucose; AGPase: ADP-Glucose Pyrophosphorylase; bHLH2: Basic Helix-Loop-Helix transcription factor 2; bZIP: Basic Leucine Zipper transcription factor; CoA: Coenzyme A; DAG: Diacylglycerol; DES: Desaturase (the number near the Greek letter Δ indicates that the double bond is created at a fixed position from the carboxyl end of a fatty acid chain); DGAT: Diacylglycerol Acyltransferase; DGLA: Diacylglycerol Lipase Alpha; DHA: Docosahexaenoic Acid; DOF: DNA binding with One Finger -type transcription factors; DPA: Docosapentaenoic Acid; DTA: Docosatetraenoic Acid; ELO: Elongase; EPA: Eicosapentaenoic Acid; ETA: Eicosatetraenoic Acid; FAS: Fatty Acid Synthase; G1P: Glycerol-1-Phosphate; G3P: Glycerol-3-Phosphate; GK: Glycerol Kinase; GLA: γ-Linolenic Acid; GPAT: Glycerol-3-Phosphate Acyltransferase; KAS: Beta-Ketoacyl-Acyl-carrier-protein Synthase; LA: Linoleic Acid; LPA: Lysophosphatidic Acid; LPAAT: Lysophosphatidic Acid Acyltransferase; MCAT: Malonyl CoA-Acyl carrier protein Transacylase; ME: Malic Enzyme; OA: Oleic Acid; OAA: Oxalacetic Acid; PA: Palmitic Acid; PAP: Phosphatidic Acid Phosphatase; PEP: Phosphoenolpyruvate; PEPC: Phosphoenolpyruvate Carboxylase; PDAT: Phospholipid Diacylglycerol Acyltransferase; PDH: Pyruvate Dehydrogenase; PDK: Pyruvate Dehydrogenase Kinase; PSR: Phosphorus Stress Response transcription factor; PTA: Phosphatidic acid; SA: Stearic acid; SDA: Stearidonic Acid; TAG: Triacylglycerol; TE/FAT: Thioesterase/Acyl-ACP Thioesterase; UDP-glucose: Uracil-Diphosphate Glucose; UGPase: UDP-Glucose Pyrophosphorylase; WRI: WRINKLED1 transcription factor; ZnCys: Zinc/Cysteine transcription factor.
Microalgae and their derivatives used as feed in farming or aquaculture. The table includes microalgal species involved, application as feed, innovations, and nutritional values indicated as percentage increase respect to a basal diet.
| Microalgal Species | Application (as Feed or Food) | Innovation | Nutritional Value (Respect to Basal Diet) | Reference |
|---|---|---|---|---|
| generic microalgae | Feed for light lamb | mixed with extruded linseed could, in part, replace fish meat | +520% ALA | [ |
| generic microalgae | Feed for Pacific lamprey | complete replacement of yeast + fish oil | +21% total LC-PUFA; +9% total ω3 PUFA; +11% EPA | [ |
| Feed for Atlantic salmon | complete replacement of fish oil | +100% DHA | [ | |
| Feed for Nile tilapia | complete replacement of fish meat | +23% total PUFA; | [ | |
| Feed for tambaqui | complete replacement of fish meat | +300% total ω3 PUFA; +200% PA; | [ | |
| Feed for Atlantic salmon | the complete replacement of fish | +6% SFA; | [ | |
| Feed for Rainbow Trout | complete replacement of fish meat | +18% total PUFA | [ | |
| Feed for red seabream | complete replacement of fish meat | +130% SFA; +180% PA; +100% DHA; | [ | |
| Feed for broiler chicken | 0.2% | +2.5% total USFA | [ | |
| Feed for channel catfish | +2% dried | +3.71% total ω3 LC-PUFA; | [ | |
| Feed for shrimps | until 75% replacement of fish meat | +100% total ω6 PUFA; | [ | |
| Feed for light lamb | 3.8% | +400% ALA; | [ | |
| Feed for rabbit | 4 gr | +50% EPA; | [ | |
| Feed for Atlantic salmon | 50% | +2% PA; | [ | |
|
| Feed for grouper | in combination with soybean meal, soy protein concentrate could replace 40% of fish meat | +100% DHA; | [ |
|
| General aquaculture feed | 48% | +80% SA; | [ |
| Feed for black tiger shrimp | 1–2% | +200% total MUFA; +10% total SFA; | [ | |
| Feed for European seabass | 20% of protein and 36% of lipid could be replaced using the freeze-dried | +4% total ω3 PUFA; +13% total SFA | [ | |
|
| Feed for silverfish | 24–26% fish oil replacement | +10% DHA; +10% total LC-ω3 PUFA | [ |
|
| Feed for Atlantic salmon | 6% dried | same nutritional content | [ |
| Feed for gilthead seabream | 2–5% | +16% total SFA; | [ | |
|
| Feed for Rainbow Trout | 10 gr | - | [ |
| Feed for broiler chicken | 7.5% | +25% total lipids | [ | |
|
| Feed for Nile tilapia | 30% | - | [ |
|
| Feed for broiler chicken | 10 gr | same nutritional content | [ |
| Feed for African catfish | ultill 75% | +20% total ω6 PUFA; +50% DHA | [ | |
| Feed for crucian carp | in combination with 2 gr cellulases per kg could completely replace fish meat | - | [ | |
| Feed for Channel Catfish | 15% | +75% PA; +30% OA; +100% EPA; +70% DHA; | [ | |
| Feed for European seabass | 15% | +2% total ω6 PUFA | [ | |
|
| Feed for Nile tilapia | 30% | - | [ |
|
| Feed for gilthead seabream | 2% | +80% EPA; | [ |
| Feed for kuruma shrimp | 4–7–10% | +13% total ω3 PUFA; +44% total ω6 PUFA; | [ | |
| Feed for European seabass | 5–10–15% | same nutritional content | [ | |
|
| Feed for Nile tilapia | complete replacement of fish meat | +47% total ω6 PUFA; | [ |
| Feed for European seabass | complete replacement of fish meat | +50% total PUFA; +70% total ω6 PUFA | [ | |
|
| Feed for oyster | complete replacement of fish meat | - | [ |
|
| Feed for shrimps | complete replacement of fish meat | - | [ |
|
| Feed for shrimps | 50% | +2% total lipids | [ |
| Feed for gilthead seabream | 10% | same total lipids | [ | |
| Feed for European seabass | combination of both microalgae for a complete replacement of fish meat | - | [ | |
| Feed for Atlantic salmon | 20% | - | [ | |
| Feed for gilthead seabream | blend of poultry and one of two algal oils | +200% total ω6 LC-PUFA; | [ | |
| Feed for Rainbow Trout | blend of three microalgae for a complete replacement of fish meat | +80% total PUFA; | [ | |
| Feed for Nile tilapia | Blend of both microalgae for a complete replacement of fish meat | +20% PA; +50% DHA; | [ |